Cyclopharm Limited Stock
Stocks
CYC
AU000000CYC5
Advanced Medical Equipment & Technology
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5850 AUD | -.--% |
|
+4.46% | -40.31% |
| 05-08 | Cyclopharm Limited Announces Retirement of Kevin Barrow from the Board | CI |
| 05-04 | Cyclopharm Appoints Chair | MT |
| Market Cap | 73.75M 51.77M 45M 41.89M 38.46M 72.62M 4.94B 494M 194M 2.46B 194M 190M 8.25B | P/E 2026 * |
-3.95x | P/E 2027 * | -8.46x |
|---|---|---|---|---|---|
| Enterprise Value | 73.75M 51.77M 45M 41.89M 38.46M 72.62M 4.94B 494M 194M 2.46B 194M 190M 8.25B | EV / Sales 2026 * |
2.01x | EV / Sales 2027 * | 1.6x |
| Free-Float |
58.05% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Cyclopharm Limited
| 1 week | +4.46% | ||
| 1 month | +17.00% | ||
| 3 months | -19.31% | ||
| 6 months | -50.00% | ||
| Current year | -40.31% |
| 1 week | 0.52 |  | 0.65 |
| 1 month | 0.46 | | 0.66 |
| Current year | 0.45 | | 1.29 |
| 1 year | 0.45 | | 1.29 |
| 3 years | 0.45 | | 3.15 |
| 5 years | 0.45 | | 3.15 |
| 10 years | 0.45 | | 3.45 |
| Manager | Title | Age | Since |
|---|---|---|---|
James McBrayer
CEO | Chief Executive Officer | 60 | 21/10/2009 |
Jason Smith
DFI | Director of Finance/CFO | - | 26/02/2024 |
Mathew Farag
COO | Chief Operating Officer | - | 01/01/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
James McBrayer
BRD | Director/Board Member | 60 | 03/06/2008 |
Dianne Angus
BRD | Director/Board Member | 65 | 10/08/2021 |
Kevin Barrow
BRD | Director/Board Member | - | 01/09/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/12/26 A | Buy | Chief Executive Officer | 10,526 | 0.0087% | ||
| 2/26/25 A | Buy | Director | 13,500 | 0.0121% | ||
| 2/26/25 A | Buy | Chairman | 8,874 | 0.0080% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +4.46% | -43.75% | -75.11% | 51.77M | |
| -0.43% | +1.06% | +24.03% | +3.71% | 212B | |
| -0.61% | +1.82% | -1.07% | -24.39% | 137B | |
| +0.10% | +4.69% | -26.86% | +12.57% | 125B | |
| +1.59% | +5.60% | -55.67% | -7.68% | 69.46B | |
| -0.98% | +4.16% | +8.50% | +7.08% | 49.56B | |
| -0.91% | +5.13% | -20.61% | -25.35% | 47.2B | |
| -0.25% | -0.14% | +21.91% | +8.35% | 39.08B | |
| -0.79% | +0.70% | +29.97% | +29.32% | 37.05B | |
| +0.00% | +5.67% | +116.67% | +8.20% | 30.97B | |
| Average | -0.23% | +3.27% | +5.31% | -6.33% | 74.76B | |
| Weighted average by Cap. | -0.24% | +2.77% | +3.69% | -0.94% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 36.6M 25.69M 22.33M 20.79M 19.09M 36.04M 2.45B 245M 96.17M 1.22B 96.49M 94.37M 4.09B | 46.2M 32.43M 28.19M 26.24M 24.09M 45.5M 3.1B 309M 121M 1.54B 122M 119M 5.17B |
| Net income | -18.9M -13.27M -11.53M -10.73M -9.86M -18.61M -1.27B -127M -49.66M -631M -49.83M -48.73M -2.11B | -9.9M -6.95M -6.04M -5.62M -5.16M -9.75M -663M -66.28M -26.01M -330M -26.1M -25.53M -1.11B |
| Net Debt | - | - |
Employees
109
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | A$0.5850 | -.--% | 828 |
| 30/07/26 | A$0.5850 | -1.68% | 35,655 |
| 29/07/26 | A$0.5950 | +14.42% | 188,038 |
| 28/07/26 | A$0.5200 | -3.70% | 13,755 |
| 27/07/26 | A$0.5400 | -3.57% | 5,865 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.4106USD
Average target price
0.6940USD
Spread / Average Target
+69.00%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CYC Stock
Select your edition
All financial news and data tailored to specific country editions
